This company has shut down. Hermes Life Sciences is no longer operating — its last tracked round was a Grant in 2021.
Explore the Startup GraveyardHermes Life Sciences develops solutions to improve the accuracy and accessibility of blood testing at the point-of-care.
Hermes Life Sciences has raised $925K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Hermes Life Sciences's investors include National Science Foundation.
Hermes Life Sciences is headquartered in Rockville, United States.
Hermes Life Sciences develops solutions to improve the accuracy and accessibility of blood testing at the point-of-care.
Hermes Life Sciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hermes Life Sciences — Funding & Investors." VCBacked, August 1, 2021, https://www.vcbacked.co/company/hermes-life-sciences. Accessed August 14, 2026.
VCBacked. (2021). Hermes Life Sciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hermes-life-sciences
{{cite web |title=Hermes Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/hermes-life-sciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated